ϸ°ûÉúÎïѧ£º mh35S!I3I^
Ò»¡¢ Ãû´Ê½âÊÍ£º
j]m|}n
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© l"%WXi"X
2£® PCR£¨96£© = Q"(9[Az
3£® ·ºËØ£¨ubquitin£©£¨96£© Hk?E0.
4£® °é·Ö×Ó£¨chapron£©£¨96£© 2[Xe:)d
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© 6>b'
g
~I
6£® DG£IP3£¨96£© zLg_0r*h1
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© G{0f*
cH)
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© a>S-50
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© !X 0 (4^
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© Tj=@5lj0
11£® Transformation£¨92£© =cxG4R1x
12£® TransfectionתȾ£¨92£©
(Kj>Ao
13£® Transcytosis×ªÒÆ×÷Óã¨92£© KJ_L>$
]*
14£® Transductionתµ¼£¨92£© 8KWhXF
15£® Transdetermination£¨92£© %3T:W\h
16£® Transdifferentiation£¨92£©
yn04[PN2
17£® Transgenic animalת»ùÒò¶¯Î92£© wV'_{/WM
18£® Rb£1£¨92£© Q`U
g tL
19£® P53£¨92¡¢91£© >Vb V<ak
20£® C£jun£¨92£© t}gK)"g
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© 6e;8\1^
22£® °ûÄÚÌ壨99£© ~HXZ-
*
23£® Cyclin dependent kinase inhibitor(CDKI)(99) |2&|#K4k^
24£® G£protein£¨91£© &sGLm~m#
25£® Restriction point£¨91£© !&o>zU.
26£® Antipost£¨91£© tfjb G;R
27£® Capping£¨91£© >|JMvbje
28£® TATAbox£¨91£© O9Yk5b;
29£® cDNA library£¨90£© #DcK{|ty
30£® Aritotic apparatus£¨90£© s$VLVT*6
31£® ¿çĤÐźŠtransmembrane signal£¨90£© Do;rY\sY
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© w4Ku1G#jC
33£® Nuclear lamina£¨90£© M:w]g` LKl
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© dZ\T@9+j+
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© iD2>-yf
36£® ϸ°û·Ö»¯£¨00£© Xj21:IMR
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© "`5BAv;u
38£® ¿Ë¡£¨00£© m ,TYF
39£® »ùÒò×飨00£© BO;LK-V
40£® Caspase£¨00£© .?.Q[ic
41£® ת¼Òò×Ó£¨00£© YQ5d!a.
42£® ÅßÌ¥¸Éϸ°û£¨01£© mOx
>
p"n
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© U6oab9C?k
44£® DNAоƬ£¨01£© If(IG]>`D
¶þ¡¢ ÎÊ´ðÌ⣺ ;,:w%.
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© U`ELd:
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æä¹¦ÄÜ£¨95£© p\M\mK
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© 1 *$-.
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© uJ/&!q<3
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© -44''w?z
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© Sc&p*G
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© <2 S?QgR,
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© h-[FUPfuw
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© I ?i,21:5
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿ØÏ¸°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£©
|HB
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷ÍÆ¶¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© I;Bci m;
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© L\X2Olfz1
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© D[}qhDlX
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© qct:xviH<|
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹ØÏµ£¨95£© 1]Gp\P}
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© p=8?hI/bim
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æä¹¦ÄÜ£¨93£© 4
g^oy^~
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© eLAhfG
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© Se
%"C&
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æä¶¨Î»¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© Nb@zn0A(;
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäĿǰËùÖªµÄ¹¦ÄÜ£¨01£© T)PH
8 "
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖØµãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© 6H}8^'/u
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© lVQy
{`Ns
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© 3F6=/
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© iSxuor^;
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆÚµÄµ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© >
H(o=39s
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹ØÏµ£¨91£© ]DO"2r
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© jVtRn.qh
29£® ÊÔÊöºáÎÆ¼¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© kX^Y{73
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æä¹¦ÄÜ£¨95£© 0QxE6>xL=
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© $pg1Av7l
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© `<:D.9vO "
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© I6E!$}
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© zn@yt%PCV
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©